- Home
- PHVS vs CRSR Comparison
PHVS vs CRSR Comparison
Compare PHVS & CRSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- CRSR
- Stock Information
- Founded
- PHVS 2015
- CRSR 1994
- Country
- PHVS Switzerland
- CRSR United States
- Employees
- PHVS N/A
- CRSR N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- CRSR Computer Manufacturing
- Sector
- PHVS Health Care
- CRSR Technology
- Exchange
- PHVS Nasdaq
- CRSR Nasdaq
- Market Cap
- PHVS 909.5M
- CRSR 1.1B
- IPO Year
- PHVS 2021
- CRSR 2020
- Fundamental
- Price
- PHVS $17.99
- CRSR $9.03
- Analyst Decision
- PHVS Buy
- CRSR Buy
- Analyst Count
- PHVS 6
- CRSR 6
- Target Price
- PHVS $37.17
- CRSR $10.00
- AVG Volume (30 Days)
- PHVS 62.5K
- CRSR 594.5K
- Earning Date
- PHVS 08-13-2025
- CRSR 07-31-2025
- Dividend Yield
- PHVS N/A
- CRSR N/A
- EPS Growth
- PHVS N/A
- CRSR N/A
- EPS
- PHVS N/A
- CRSR N/A
- Revenue
- PHVS N/A
- CRSR $1,348,872,000.00
- Revenue This Year
- PHVS N/A
- CRSR $14.40
- Revenue Next Year
- PHVS N/A
- CRSR $9.76
- P/E Ratio
- PHVS N/A
- CRSR N/A
- Revenue Growth
- PHVS N/A
- CRSR N/A
- 52 Week Low
- PHVS $11.51
- CRSR $5.60
- 52 Week High
- PHVS $25.50
- CRSR $13.02
- Technical
- Relative Strength Index (RSI)
- PHVS 58.65
- CRSR 52.79
- Support Level
- PHVS $16.00
- CRSR $9.00
- Resistance Level
- PHVS $17.53
- CRSR $9.49
- Average True Range (ATR)
- PHVS 1.14
- CRSR 0.34
- MACD
- PHVS 0.01
- CRSR -0.07
- Stochastic Oscillator
- PHVS 59.77
- CRSR 38.46
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About CRSR Corsair Gaming Inc.
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.